Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952360 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Forkhead Box A1 (FOXA1) (AA 270-299), (Middle Region) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 270-299, Middle Region
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references CCCTC-binding factor acts upstream of FOXA1 and demarcates the genomic response to estrogen.
A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide.
[Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas].
Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.
FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis.
Zhang Y, Liang J, Li Y, Xuan C, Wang F, Wang D, Shi L, Zhang D, Shang Y
The Journal of biological chemistry 2010 Sep 10;285(37):28604-13
The Journal of biological chemistry 2010 Sep 10;285(37):28604-13
A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide.
Hu DG, Gardner-Stephen D, Severi G, Gregory PA, Treloar J, Giles GG, English DR, Hopper JL, Tilley WD, Mackenzie PI
Molecular pharmacology 2010 Oct;78(4):714-22
Molecular pharmacology 2010 Oct;78(4):714-22
[Diagnostic and prognostic significance of FOXA1 expression in molecular subtypes of breast invasive ductal carcinomas].
Liu N, Niu Y, Wang SL, Yu Q, Zhang RJ, Liu TJ
Zhonghua yi xue za zhi 2010 May 25;90(20):1403-7
Zhonghua yi xue za zhi 2010 May 25;90(20):1403-7
Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.
Song Y, Washington MK, Crawford HC
Cancer research 2010 Mar 1;70(5):2115-25
Cancer research 2010 Mar 1;70(5):2115-25
FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis.
Bernardo GM, Lozada KL, Miedler JD, Harburg G, Hewitt SC, Mosley JD, Godwin AK, Korach KS, Visvader JE, Kaestner KH, Abdul-Karim FW, Montano MM, Keri RA
Development (Cambridge, England) 2010 Jun;137(12):2045-54
Development (Cambridge, England) 2010 Jun;137(12):2045-54
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
